EU indices slightly down | TA focus on Kingspan


European stocks report | Kingspan | Sanofi | BNP Paribas | Unibail-Rodamco-Westfield...

Stocks (2)


Yesterday, European stocks were mixed. The Stoxx Europe 600 Index gained 0.72%, Germany's DAX 30 rose 0.67% and France's CAC 40 climbed 0.66%, while the U.K.'s FTSE 100 declined 0.25%.

68% of STOXX 600 constituents traded higher yesterday.
79% of the shares trade above their 20D MA vs 73% Friday (above the 20D moving average).
64% of the shares trade above their 200D MA vs 63% Friday (above the 20D moving average).

The Euro Stoxx 50 Volatility index added 0.02pt to 22.25, a new 52w high.

3mths relative high: Industrial
3mths relative low: none

Europe Best 3 sectors
utilities, technology, automobiles & parts

Europe worst 3 sectors
travel & leisure, energy, banks

The 10yr Bund yield was unchanged to -0.53% (below its 20D MA). The 2yr-10yr yield spread rose 0bp to -18bps (above its 20D MA).

GE 07:00: Sep Inflation Rate MoM final, exp.: -0.1%
GE 07:00: Sep Harmonised Inflation Rate YoY final, exp.: -0.1%
GE 07:00: Sep Harmonised Inflation Rate MoM final, exp.: -0.2%
GE 07:00: Sep Inflation Rate YoY final, exp.: 0%
UK 07:00: Aug Average Earnings excl. Bonus, exp.: 0.2%
UK 07:00: Aug Average Earnings incl. Bonus, exp.: -1%
UK 07:00: Aug Unemployment Rate, exp.: 4.1%
UK 07:00: Sep Claimant Count chg, exp.: 73.7K
UK 07:00: Jul Employment chg, exp.: -12K
UK 07:00: Q2 Labour Productivity QoQ final, exp.: -1.3%
EC 10:00: Oct ZEW Economic Sentiment Idx, exp.: 73.9
GE 10:00: Bundesbank Wuermeling speech
GE 10:00: Bundesbank Buch speech
GE 10:00: Oct ZEW Current Conditions, exp.: -66.2
GE 10:00: Oct ZEW Economic Sentiment Idx, exp.: 77.4
GE 13:00: Bundesbank Wuermeling speech

In Asian trading hours, EUR/USD dropped to 1.1794 and GBP/USD eased to 1.3041. USD/JPY slid to 105.37.

Spot gold extended its decline to $1,913 an ounce.

Kingspan, a building materials company, was upgraded to "buy" from "hold" at Societe Generale.
From a daily point of view, the stock remains on the upside, supported by a rising trend line drawn since March. Above the horizontal support at 71.5p, look for 83p and 92p in extension.

Source: GAIN Capital, TradingView

Evotec, a drug discovery and development company, said Mubadala Investment Company and Novo Holdings will subscribe a total of 11,478,315 new shares of the company for 250 million euros (21.7802 euros per share).

Sanofi, a pharmaceutical group, reported that a phase 3 trial of its Dupixent met the primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-to-severe asthma.

BNP Paribas', a banking group, "A+" credit rating outlook was revised to "Negative" from "Watch Negative" by Fitch. The rating agency said: "The Negative Outlook on BNPP's Long-Term IDR reflects downside risks to our baseline scenario, as pressure on the ratings would increase substantially if the downturn is deeper or more prolonged than we currently expect."

Vinci, a concessions and construction company, is expected to report 3Q traffic figures for its airports.

Unibail-Rodamco-Westfield, a commercial real estate company, announced that it has agreed to sell the SHiFT office building in Paris to a consortium of French institutional investors for 620 million euros.

Adecco, a recruitment services provider, was upgraded to "overweight" from "neutral" at JPMorgan.

Rockwool International, a Danish manufacturer of mineral wool products, was upgraded to "hold" from "sell" at Societe Generale.

More from Equities

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.